pharmaphorum
SEPTEMBER 24, 2020
A potential COVID-19 breath test has been unveiled in the UK, as the country desperately searches for alternatives to crippling lockdown measures to prevent the disease from spreading. The breath test has been developed by Integumen in collaboration with Modern Water, Avacta and Aptamer Group, which had been working on test that identifies the SARS-CoV-2 coronavirus in waste water.
Pharma Mirror
SEPTEMBER 23, 2020
Pharmacists are healthcare professionals who have enough knowledge about the effective uses of medications. World Pharmacist Day is celebrated on 25th September every year since 2010 on the day FIP (International Pharmaceutical Federation) started their journey. FIP encourages pharmacists to celebrate this day to promote and support the role of the pharmacist in the whole.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Druggist
SEPTEMBER 20, 2020
Baby thrush (oral thrush) is a common condition caused by candida infection (fungal infection) and mostly affecting new-born babies. Thrush can affect breastfeeding mothers (thrush present in the breast) and babies, with thrush affecting the inside of the mouth or causing a nappy rash. This post will focus on the treatment of oral baby thrush. Parents have only one option for baby thrush treatment – over the counter antifungal oral gel (Daktarin Sugar-Free 2% Oral Gel), which be purchased
Outsourcing Pharma
SEPTEMBER 21, 2020
A leader from the pharma software solutions provider suggests streamlining communication between shifts can avoid manufacturing snags.
Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.
The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven
pharmaphorum
SEPTEMBER 23, 2020
Sixfold Bioscience and Medicines Discovery Catapult awarded Innovate UK grant to pursue ground-breaking project. Sixfold Bioscience in partnership with Medicines Discovery Catapult, has been given the green light, through the award of an Innovate UK Smart Grant to test a pioneering system designed to deliver drugs directly to cancerous cells, without impacting the healthy cells around it.
Pharma Times
SEPTEMBER 22, 2020
Data presented at 2020 ESMO virtual congress
Pharmacy Technician Pulse brings together the best content for pharmacy technicians from the widest variety of industry thought leaders.
Outsourcing Pharma
SEPTEMBER 24, 2020
The AI platform combines machine-learning models and advanced semantic technologies to help life-science users gain insights from their data.
pharmaphorum
SEPTEMBER 23, 2020
Life science companies must evolve and find new ways of working that erase the lines between industries and sub-sectors if they are to adapt to the digitalised world. That’s according to the team at Sweden’s Sahlgrenska Science Park, who are getting ready to host a virtual event looking at how the specialisation of digital expertise is driving a trend of sector convergence that pharma is only just cottoning on to.
Pharma Times
SEPTEMBER 23, 2020
European Medicines Agency grants designation based on phase I/II data
Pharma Mirror
SEPTEMBER 25, 2020
The Hague — Governments and other stakeholders must take urgent action to ensure equity in access to disease prevention measures, which includes greater investment in vaccines and vaccination services by community pharmacists. So said the International Pharmaceutical Federation (FIP) in a call to action made today at the start of a new FIP Digital Programme to.
Speaker: Chris Antypas and Josh Halladay
Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.
Outsourcing Pharma
SEPTEMBER 22, 2020
The CRO will work with the Leukemia and Lymphoma Society on a global master clinical trial to explore treatments for pediatric acute leukemia.
pharmaphorum
SEPTEMBER 21, 2020
Amazon’s Alexa device can already field health and medical questions, but the library of responses has now been bulked up thanks to a partnership with digital health company Sharecare. The new deal adds more than 80,000 questions and answers to the repertoire of the Alexa virtual assistant, which provides information, entertainment and advice to users on voice command via devices such as Amazon’s Echo smart speakers.
Pharma Times
SEPTEMBER 23, 2020
Upfront funding will be used to scale-up manufacturing
Pharma Tutor
SEPTEMBER 23, 2020
About Author AKASH GUPTA . M.Pharm (pharmaceutics). Kota college of pharmacy, Ranpur, Kota. . ABSTRACT. Comorbid depression and anxiety disorders occur in up to 25% of general practice patients. About 85% of patients with depression have significant anxiety, and 90% of patients with anxiety disorder have depression. Both the depression disorder and the specific anxiety disorder require appropriate treatment.
Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist
What will the future hold for clinical research? A recent draft from the FDA provides valuable insight. In "Optimizing the Dosage of Human Prescription Drugs and Biological Products for the Treatment of Oncologic Diseases," the FDA notes that "targeted therapies demonstrate different dose-response relationships compared to cytotoxic chemotherapy, such that doses below the Maximum Tolerated Dose (MTD) may have similar efficacy to the MTD but with fewer toxicities.
Outsourcing Pharma
SEPTEMBER 21, 2020
The latest iteration of the companyâs Pharma CEO Survey offers information and insight as to how key industry figures are planning for the future.
pharmaphorum
SEPTEMBER 21, 2020
Compass Pathways and its potential magic mushroom depression drug went public last week – and now psychedelic therapy firm Mind Medicine is aiming to follow suit by up-listing its shares on the Nasdaq. UK-based Compass has a patented synthetic version of psilocybin, the active ingredient in magic mushrooms, and raised around $127.5 million with its IPO on Friday and shares are still significantly above their launch price of $17.
Pharma Times
SEPTEMBER 21, 2020
Investors include SV Health Investors and Cancer Research UK
Med Ed 101
SEPTEMBER 23, 2020
A 69-year-old female is concerned with hair loss. She states that she does not have a family history of this issue and believes that her medications might be to blame. Her primary provider does not feel as if the hair loss is due to a medical issue (i.e. hypothyroidism etc.). Current diagnoses include: GERD Peptic […]. The post Hair Loss – Curbside Consult appeared first on Med Ed 101.
Advertisement
Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.
Outsourcing Pharma
SEPTEMBER 22, 2020
The drug discovery and pharma companies have extended their agreement to collaborate on development of new treatments for a range of therapeutic areas.
pharmaphorum
SEPTEMBER 24, 2020
An artificial intelligence-powered diagnostic for autism spectrum disorder (ASD), developed by Cognoa, has met all its objectives in a pivotal trial and will be filed for approval with the FDA. The ASD diagnostic app is designed to serve as a tool that can be used by paediatricians in primary care to detect autism traits early on and start treatment sooner.
Pharma Times
SEPTEMBER 21, 2020
Detailed results presented at ESMO also show benefit in prostate cancer
Med Ed 101
SEPTEMBER 20, 2020
The omeprazole escitalopram interaction is a relatively common one in clinical practice. Below, I outline a case scenario where this interaction may have caused some adverse effects from escitalopram. An 81-year-old female has a history of depression, GERD, hypertension, and osteoarthritis. Current medications include amlodipine 10 mg daily, hydrochlorothiazide 12.5 mg daily, escitalopram 20 mg […].
Outsourcing Pharma
SEPTEMBER 22, 2020
Thermo Fisher Scientific will partner with AstraZeneca and the University of Nebraska Medical Center to advance biomarker discovery and characterization.
pharmaphorum
SEPTEMBER 22, 2020
New research from The Patients Association, supported through sponsorship provided by Novo Nordisk and ENGINE MHP, looks at how more than 950 patients experienced the COVID-19 pandemic, with an emphasis on managing and accessing care and their experiences of treatment and services more broadly. Here, Patients Association CEO Rachel Power and ENGINE MHP director Jonathon Sheppard explore some of the findings – such as major disruptions to the relationships between patients and the health and care
Pharma Times
SEPTEMBER 21, 2020
Positive opinions include Pacira's Exparel and two new vaccines from Sanofi
pharmaphorum
SEPTEMBER 24, 2020
Although life for the general public is (slowly) starting to edge back towards normality, healthcare providers are still on a heightened state of alert. In the UK, the 1 August step down from EPRR incident level four may have meant we’re no longer in a state of national incident, but at a regional level NHS Trusts and private sector providers are still very much working flat out to manage and contain COVID-19 and its associated fallout.
pharmaphorum
SEPTEMBER 22, 2020
A UK university has struck a partnership with medical technology firm Better that aims to give nursing and pharmacy students a better insight into e-prescribing. Liverpool John Moores University is to use Better’s OPENeP electronic prescribing and medicines administration software to teach the students about modern prescribing practices. OPENeP is designed as a stand-alone product that allows electronic patient record systems to be integrated with medication-related decision support systems.
pharmaphorum
SEPTEMBER 23, 2020
One of the less well-known symptoms of COVID-19 is inflammation and injury to blood vessels, and US biotech Aerpio Pharma thinks it has a drug that may help avert the life-threatening blood clots that can result. Ohio-based Aerpio has started a phase 2 trial of its razuprotafib drug, given as a subcutaneous injection three times a day, to hospitalised subjects with moderate to severe COVID-19, to see if it can stabilise blood vessels in their lungs and other organs.
pharmaphorum
SEPTEMBER 24, 2020
Gilead has paid $97 million to resolve claims by US authorities that it acted illegally by using a charitable foundation as a conduit to fund co-payments of thousands of Medicare patients taking its pulmonary arterial hypertension drug, Letairis. While this may sound innocuous, the US Department of Justice is cracking down on this activity as it undermines US laws that aim to place a check on drug prices on the federally-funded Medicare scheme.
pharmaphorum
SEPTEMBER 24, 2020
The UK could be the first country to carry out a COVID-19 “challenge trial” where healthy volunteers are deliberately infected with coronavirus to test vaccines, according to press reports. First reported by the Financial Times, the stories suggest that the first such studies would be of help in London, as the country desperately searches for a solution to soaring infection rates.
pharmaphorum
SEPTEMBER 21, 2020
Immunomedics has revealed the trial data that convinced Gilead to stage a $21 billion takeover , after the biotech’s Trodelvy significantly extended survival in patients with tough-to-treat triple negative breast cancer. In April, Trodelvy was conditionally approved in the US in triple-negative breast cancer (TNBC) on the basis of a phase 1/2 study, which showed a response rate of 33%.
pharmaphorum
SEPTEMBER 24, 2020
The UK government has finally launched its COVID-19 test and trace app months behind schedule as the country faces a second wave of the potentially deadly virus. There have already been hundreds of thousands of downloads of the app, which was seen as a key part of the government’s strategy to fight the virus when it was announced in May. But a pilot scheme of the app in the Isle of Wight hit problems almost immediately because of the government’s decision to use a centralised database, instead o
pharmaphorum
SEPTEMBER 25, 2020
Novavax has begun a late-stage trial of its experimental COVID-19 vaccine in the UK, which could support filings for a licence in the UK, EU and other countries. The UK government has already signed an agreement with the US biotech to buy 60 million doses of the vaccine in August if trials work out. It’s one of several agreements with major vaccine makers as the UK hedges its bets over which of the shots will get okayed by regulators first.
Expert insights. Personalized for you.
143 
Let's personalize your content